Fig. 2From: Hyperprogression after immunotherapy in patients with malignant tumors of digestive systemPairwise comparisons of TGK on immunotherapy (TGKPOST) and TGK pre-immunotherapy (TGKPRE) in 25 patients with malignant tumors of digestive system enrolled and treated in phase I clinical trials with ICIs. Each dot represents a patientBack to article page